Main Menu

NASDAQ (usa) arrow 6715.56 -12.11 -0.18%
FTSE 100 (london) arrow 7487.96 -5.12 -0.07%
DAX (german) arrow 13465.51 235.94 1.78%
NIKKEI 225 (japan) arrow 22420.08 408.47 1.86%
Hang - Seng (hong kong) arrow 28594.06 348.52 1.23%
NIFTY - 50 (india)
Straits Times (singapore) arrow 3391.61 17.53 0.52%
KOSPI (korea) arrow 2556.47 33.04 1.31%
All Ordinaries (australia) arrow 6005.30 28.90 0.48%
BOVESPA (brazil) arrow 74092.76 -215.73 -0.29%

Enanta Pharmaceuticals Inc (NASDAQ: ENTA)

 
ENTA Technical Analysis
5
As on 12th Dec 2025 ENTA STOCK Price closed @ 14.73 and we RECOMMEND Strong Buy for LONG-TERM with Stoploss of 7.25 & Strong Buy for SHORT-TERM with Stoploss of 6.16 we also expect STOCK to react on Following IMPORTANT LEVELS.
 
 

ENTASTOCK Price

Open 14.13 Change Price %
High 14.95 1 Day 0.59 4.17
Low 13.98 1 Week 0.49 3.44
Close 14.73 1 Month 3.87 35.64
Volume 254919 1 Year 6.13 71.28
52 Week High 15.16 | 52 Week Low 4.26
 
NASDAQ USA Most Active Stocks
LPTX 2.05 365.91%
AMRS 0.14 100.00%
WBA 11.98 0.50%
OCG 0.22 -75.82%
NVDA 175.02 -3.27%
CGC 1.74 53.98%
LMDX 0.02 0.00%
PLUG 2.32 -1.69%
YGMZ 0.02 -66.67%
AKTS 0.04 0.00%
 
NASDAQ USA Top Gainers Stocks
MRIN 3450.00 383233.34%
MRIN 3450.00 383233.34%
ARBK 6.87 4807.14%
ARBK 6.87 4807.14%
KTRA 6.30 2763.64%
IDRA 8.64 1909.30%
REDU 3.41 1075.86%
CTXRW 0.14 600.00%
LPTX 2.05 365.91%
NDRAW 0.03 200.00%
 
NASDAQ USA Top Losers Stocks
TBIO 0.00 -100.00%
HTOOW 0.00 -100.00%
ARKOW 0.00 -100.00%
ZWZZT 0.01 -99.96%
FPAY 0.01 -94.74%
OTIC 0.01 -91.67%
PTRAW 0.23 -89.59%
SWSSU 1.06 -89.40%
OTRK 0.07 -78.79%
OCG 0.22 -75.82%
 
 
ENTA
Daily Charts		 ENTA
Intraday Charts		 Whats New @
Bazaartrend		 ENTA
Free Analysis
 
ENTA Important Levels Intraday
RESISTANCE16.60
RESISTANCE16.00
RESISTANCE15.63
RESISTANCE15.26
SUPPORT14.20
SUPPORT13.83
SUPPORT13.46
SUPPORT12.86
 
ENTA Forecast December 2025
Share
4th UP Forecast18.08
3rd UP Forecast17.01
2nd UP Forecast16.34
1st UP Forecast15.68
1st DOWN Forecast13.78
2nd DOWN Forecast13.12
3rd DOWN Forecast12.45
4th DOWN Forecast11.38
 
ENTA Weekly Forecast
4th UP Forecast18.60
3rd UP Forecast17.36
2nd UP Forecast16.59
1st UP Forecast15.83
1st DOWN Forecast13.63
2nd DOWN Forecast12.87
3rd DOWN Forecast12.10
4th DOWN Forecast10.86
 
ENTA Forecast2025
4th UP Forecast36.41
3rd UP Forecast29.46
2nd UP Forecast25.16
1st UP Forecast20.86
1st DOWN Forecast8.6
2nd DOWN Forecast4.3
3rd DOWN Forecast0
4th DOWN Forecast-6.95
 
 
ENTA Other Details
Segment EQ
Market Capital 1728213760.00
Sector Healthcare
Industry Biotechnology
Offical website >
 
ENTA Address
ENTA
 
ENTA Latest News
 
Your Comments and Response on Enanta Pharmaceuticals Inc
 
ENTA Business Profile
Enanta Pharmaceuticals, Inc., a biotechnology company, discovers and develops small molecule drugs for the treatment of viral infections and liver diseases. Its research and development disease targets include respiratory syncytial virus, non-alcoholic steatohepatitis, SARS-CoV-2, human metapneumovirus, and hepatitis B virus. The company offers glecaprevir for the treatment of chronic hepatitis C virus, or HCV under the MAVYRET and MAVIRET names. Enanta Pharmaceuticals, Inc. has a collaborative development and license agreement with Abbott Laboratories to identify, develop, and commercialize HCV NS3 and NS3/4A protease inhibitor compounds, including paritaprevir and glecaprevir for the treatment of chronic hepatitis C virus. The company was founded in 1995 and is headquartered in Watertown, Massachusetts. Address: 500 Arsenal Street, Watertown, MA, United States, 02472
 
© 2005-2023 BazaarTrend.com All rights reserved.

Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service